| This week's sponsor is Premier Research. | |  | Taking the Fight to Rare Cancers
Beating rare cancers demands expertise in oncology and rare diseases. Our white paper shows how adaptive design, study committees, and cross-industry cooperation are fueling real progress. Premier Research. Built for biotech. |
Today's Rundown Featured Story | | | Tuesday, August 27, 2019 When I first started being a biopharma reporter back in the recession period of 2009 when Pfizer and Merck were in the midst of megamergers, I remember asking my then-editor a question that really irked him. |
|
|
Top Stories Tuesday, August 27, 2019 GlaxoSmithKline has licensed Ionis Pharmaceuticals’ antisense hepatitis B medicines for $25 million. The deal comes shortly after GSK achieved clinical proof of concept for the Ionis-partnered hepatitis B program. Tuesday, August 27, 2019 A phase 2b trial of InDex Pharmaceuticals’ ulcerative colitis drug has met its primary endpoint. The trial linked use of the highest dose of the topical TLR9 agonist to a 15% improvement in the clinical remission rate over placebo. Tuesday, August 27, 2019 Adaptimmune has struck a deal to access Noile-Immune Biotech’s technology for improving cancer cell therapies. The collaboration is expected to move a Spear T-cell cancer candidate based on the technology into human testing in 2021. Tuesday, August 27, 2019 Bristol-Myers Squibb will use Presage’s microdosing technology to assess early-stage cancer targets in phase 0—a stage in drug development designed to bridge preclinical and clinical work. Monday, August 26, 2019 Thomas Neff founded FibroGen in 1993 and has led the company for decades. Now, the company is searching for its next leader with his unexpected death over the weekend. Neff's passing comes as FibroGen nears key filings. | This week's sponsor is ExL Events. | |  | |
Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|
Resources Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Wesco Pharmaceutical Solutions and WBR Insights The regulations and managing processes for hazardous, controlled and rare chemicals and biologics necessary for drug discovery are a huge distraction for R&D labs. Learn from the perspectives of industry executives the pain points and improvements they want in their processes for chemicals and biologics in pharmaceuticals R&D. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Patheon, by Thermo Fisher Scientific Patheon, part of Thermo Fisher Scientific, offers advanced API manufacturing technologies such as continuous processing and continuous analytics to deliver high-quality products with well-defined features to meet your timelines and volume requirements. Sponsored by: ICON Understanding the challenges for formulary decision makers and manufacturers. Sponsored by: Veeva This white paper details how leveraging new reporting capabilities, live UAT feedback sessions, and an agile design approach to study builds will save them time and money. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. | 
